Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 8, 2025
Electe Joins the World Wide Web Consortium as a AI B2B Go-to-Market Leader
EIN Presswire
·
April 8, 2025
Italian AI analytics platform becomes W3C member to influence data interoperability and privacy standards for small and medium-sized enterprises MILANO, MI, ITALY, April 8, 2025 /EINPresswire.com/ -- Electe, an Italian company leading in AI-based data …
Stem Vitality Mexico Announces Expanded Access to Affordable Stem Cell Treatments for Patients from the U.S. and Canada
EIN Presswire
·
April 8, 2025
TIJUANA, MEXICO, April 8, 2025 /EINPresswire.com/ -- Stem Vitality Mexico is pleased to announce it is now accepting new patients seeking safe and effective stem cell therapy for a wide range of conditions. By offering treatments at a fraction of the …
ECCO Medical Launches ECCO Vein Center to Bring Comprehensive Minimally Invasive Vein Care To Colorado’s Front Range
EIN Presswire
·
April 8, 2025
Specialized Interventional Radiology Nurse Practitioners Now Offering Minimally Invasive Vein Treatments at Two Convenient Locations DENVER, PUEBLO, CO, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- ECCO Medical, Colorado’s leader in minimally …
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
GlobeNewswire
·
April 8, 2025
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the …
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
GlobeNewswire
·
April 8, 2025
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief …
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
GlobeNewswire
·
April 8, 2025
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of a $ …
National Minority Quality Forum Announces 2025 National Minority Health Month Theme: “Health Unlocked: Access, Alignment, Action”
GlobeNewswire
·
April 8, 2025
Washington, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- The National Minority Quality Forum (NMQF) proudly announces the 2025 theme for National Minority Health Month: “Health Unlocked: Access, Alignment, Action.” This year’s theme recognizes the evolving …
Myriad Genetics Announces Inducement Awards
GlobeNewswire
·
April 8, 2025
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that in connection with the hiring of Mr. Donnelly as chief commercial officer, …
AMN Healthcare to Hold First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025
GlobeNewswire
·
April 8, 2025
DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. …
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 8, 2025
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6 …
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire
·
April 8, 2025
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that …
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire
·
April 8, 2025
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI …
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward …
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 8, 2025
NX-5948 assigned the nonproprietary name “bexobrutideg” U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemia Achieved $7M in milestones and a $15M license extension fee from ongoing collaboration with …
Tano Jones Revelry Opens For Sister Hazel - Thursday, April 10, 2025 - The Clayton Center - Raleigh, NC Triangle
EIN Presswire
·
April 8, 2025
Billboard Charting band The Tano Jones Revelry will bring their Hits "What About Me", "Light It", "Daisy" to the Raleigh, NC area on Thursday, April 10, 2025 DETROIT, MI, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The Tano Jones Revelry will be …
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
GlobeNewswire
·
April 8, 2025
New York, USA, April 08, 2025 (GLOBE NEWSWIRE) -- Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight The treatment paradigm for DEE is expected to evolve in the coming years. …
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
GlobeNewswire
·
April 8, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, …
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
GlobeNewswire
·
April 8, 2025
CHICAGO, April 08, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
GlobeNewswire
·
April 8, 2025
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced …
AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
GlobeNewswire
·
April 8, 2025
BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA (WODC), …